We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.6%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$27.1B
AUM Growth
+$3.44B
Cap. Flow
+$921M
Cap. Flow %
3.4%
Top 10 Hldgs %
34.67%
Holding
1,351
New
69
Increased
716
Reduced
273
Closed
50

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$162M
2
SBAC icon
SBA Communications
SBAC
+$111M
3
ESS icon
Essex Property Trust
ESS
+$96.7M
4
MAA icon
Mid-America Apartment Communities
MAA
+$92.5M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$75.9M

Top Sells

Rank Stock Value
1
OHI icon
Omega Healthcare
OHI
+$137M
2
AMT icon
American Tower
AMT
+$116M
3
PSA icon
Public Storage
PSA
+$97.9M
4
UDR icon
UDR
UDR
+$80.4M
5
AVB icon
AvalonBay Communities
AVB
+$73.9M

Sector Composition

Rank Sector Weight
1 Real Estate 30.73%
2 Technology 27.75%
3 Communication Services 10.3%
4 Consumer Discretionary 6.75%
5 Financials 6.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRUS
1101
DELISTED
Merus
MRUS
$13K ﹤0.01%
246
– –
DCBO
1102
Docebo
DCBO
$533M
$12K ﹤0.01%
420
-605
-59% -$17.2K
PTGX icon
1103
Protagonist Therapeutics
PTGX
$8.8B
$12K ﹤0.01%
215
– –
RARE icon
1104
Ultragenyx Pharmaceutical
RARE
$2.56B
$12K ﹤0.01%
340
+35
+11% +$1.26K
SRRK icon
1105
Scholar Rock
SRRK
$5.92B
$12K ﹤0.01%
341
+32
+10% +$1K
USHY icon
1106
iShares Broad USD High Yield Corporate Bond ETF
USHY
$29.2B
$12K ﹤0.01%
328
+294
+865% +$10.8K
KYMR icon
1107
Kymera Therapeutics
KYMR
$8.73B
$11K ﹤0.01%
245
– –
LEGN icon
1108
Legend Biotech
LEGN
$3.68B
$10K ﹤0.01%
294
-7,432
-96% -$241K
NFE icon
1109
New Fortress Energy
NFE
$94.3M
$10K ﹤0.01%
3,020
-1,260
-29% -$5.47K
ALVO icon
1110
Alvotech
ALVO
$1.05B
$9K ﹤0.01%
1,030
– –
CRNX icon
1111
Crinetics Pharmaceuticals
CRNX
$8.88B
$9K ﹤0.01%
304
– –
IMVT icon
1112
Immunovant
IMVT
$7.99B
$9K ﹤0.01%
581
– –
MIRM icon
1113
Mirum Pharmaceuticals
MIRM
$6.84B
$9K ﹤0.01%
178
+30
+20% +$1.34K
AMRX icon
1114
Amneal Pharmaceuticals
AMRX
$5.99B
$8K ﹤0.01%
1,023
– –
IBRX icon
1115
ImmunityBio
IBRX
$7.3B
$8K ﹤0.01%
3,173
+553
+21% +$1.49K
TWST icon
1116
Twist Bioscience
TWST
$5.51B
$8K ﹤0.01%
210
– –
XENE icon
1117
Xenon Pharmaceuticals
XENE
$6.28B
$8K ﹤0.01%
252
– –
AGIO icon
1118
Agios Pharmaceuticals
AGIO
$2.14B
$7K ﹤0.01%
204
– –
APGE icon
1119
Apogee Therapeutics
APGE
$10.1B
$7K ﹤0.01%
166
+35
+27% +$1.33K
APLS
1120
DELISTED
Apellis Pharmaceuticals
APLS
$7K ﹤0.01%
429
– –
CGON icon
1121
CG Oncology
CGON
$6.41B
$7K ﹤0.01%
274
+51
+23% +$1.23K
DNLI icon
1122
Denali Therapeutics
DNLI
$3.82B
$7K ﹤0.01%
475
– –
INDV icon
1123
Indivior Pharmaceuticals
INDV
$4.85B
$7K ﹤0.01%
450
– –
LGND icon
1124
Ligand Pharmaceuticals
LGND
$5.94B
$7K ﹤0.01%
63
– –
NAMS icon
1125
NewAmsterdam Pharma
NAMS
$3.27B
$7K ﹤0.01%
375
– –
43 44
45
46 47

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q2 2025 Portfolio in Review

As of Q2 2025, Daiwa Securities Group held 1,351 positions worth $27.1B, up 15% from $23.7B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group deployed $921M of net new capital in Q2 2025, opening 69 new positions and adding to 716 existing holdings. Its largest new stake was SmartStop Self Storage REIT: 313,858 shares worth $11.4M.

By sector, the portfolio is most concentrated in Real Estate at 31% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Omega Healthcare, an estimated $137M trimmed.

  • Daiwa Securities Group's largest Q2 2025 buy was SmartStop Self Storage REIT: 313,858 shares worth $11.4M.
  • Daiwa Securities Group added most to Apple in Q2 2025, an estimated $162M increase.
  • Daiwa Securities Group's biggest Q2 2025 reduction was Omega Healthcare, cutting an estimated $137M.
  • Daiwa Securities Group fully exited iShares Core US Aggregate Bond ETF in Q2 2025, selling an estimated $10.3M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $27.1B portfolio in Q2 2025.
  • Daiwa Securities Group opened 69 new positions and closed 50 in Q2 2025.
  • Daiwa Securities Group's portfolio value rose 15% quarter-over-quarter to $27.1B.

Based on Daiwa Securities Group's 13F filing for Q2 2025, filed 14 Aug 2025.